Steven R Sanislo, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sanislo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G74925 · Current
Licensed to practise in California · since 1992 · expires 2028-04-30 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$310,060
Medicare paid this office $310,060 for 1,020 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection of drug into eye | 182 | $78,307 | $90 |
| Established patient complete exam of visual system | 716 | $58,627 | $62 |
| Return visit (30+ min) | 309 | $49,169 | $79 |
| Imaging of retina | 953 | $35,686 | $21 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 14 | $14,771 | $1,055 |
See all 16 services
| Injection of drug into eye | 182 | $78,307 | $90 |
| Established patient complete exam of visual system | 716 | $58,627 | $62 |
| Return visit (30+ min) | 309 | $49,169 | $79 |
| Imaging of retina | 953 | $35,686 | $21 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 14 | $14,771 | $1,055 |
| Removal of cataract with insertion of prosthetic lens | 21 | $14,719 | $491 |
| Removal of eye fluid (vitreous) between lens and retina | 14 | $8,995 | $642 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $7,403 | $673 |
| New patient complete exam of visual system | 77 | $5,681 | $74 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $4,897 | $288 |
| New patient visit (45+ min) | 30 | $3,171 | $106 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 28 | $987 | $34 |
| Measurement of corneal curvature and depth of eye | 33 | $763 | $23 |
| Exam of visual field with extended testing | 25 | $673 | $24 |
| Imaging of optic nerve | 21 | $383 | $17 |
| Photography of the retina | 14 | $265 | $16 |
Procedures Medicare counted
| Cataract surgery | 47 | More than 62% of doctors who do this |
Who their Medicare patients are
1,020 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 22% · Women 57% · Also on Medicaid 23% · Health risk score 1.37. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 70% · Diabetes 39% · Coronary heart disease 27% · Chronic kidney disease 22% · Atrial fibrillation 19% · Cancer 17% · Heart failure 16% · Depression 13% · COPD 9% · Stroke 8% · Dementia 7%.
The office billed $2,600,537, Medicare allowed $422,805 and paid $310,060; for 4,550 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,020 | 4,550 | 77 | 1.37 | $2,600,537 | $310,060 |
| 2023 | 941 | 4,343 | 77 | 1.49 | $2,219,477 | $309,094 |
| 2022 | 1,018 | 4,736 | 76 | 1.50 | $2,271,152 | $329,865 |
| 2021 | 989 | 4,785 | 76 | 1.42 | $2,214,608 | $340,684 |
| 2020 | 778 | 4,153 | 77 | 1.63 | $1,856,786 | $288,967 |
| 2019 | 1,001 | 4,989 | 76 | 1.55 | $2,197,983 | $353,225 |
| 2018 | 903 | 4,570 | 77 | 1.44 | $1,975,433 | $327,317 |
| 2017 | 821 | 4,161 | 76 | 1.49 | $2,039,638 | $308,656 |
| 2016 | 736 | 3,847 | 77 | 1.35 | $1,931,986 | $310,735 |
| 2015 | 645 | 4,535 | 78 | 1.44 | $2,665,117 | $779,296 |
| 2014 | 712 | 4,795 | 78 | 1.35 | $2,851,603 | $813,104 |
| 2013 | 679 | 4,056 | 77 | 1.31 | $2,110,142 | $575,081 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Injection of drug into eye | 189 | $85,187 | $96 |
| Established patient complete exam of visual system | 641 | $56,315 | $65 |
| Return visit (30+ min) | 277 | $51,984 | $86 |
| Imaging of retina | 872 | $35,892 | $22 |
| Removal of cataract with insertion of prosthetic lens | 23 | $15,992 | $516 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $12,714 | $1,059 |
| New patient complete exam of visual system | 63 | $4,938 | $78 |
| New patient visit (45+ min) | 33 | $3,958 | $120 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,695 | $308 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 45 | $1,918 | $38 |
| Measurement of corneal curvature and depth of eye | 28 | $801 | $28 |
| Imaging of optic nerve | 19 | $420 | $20 |
| Exam of visual field with extended testing | 14 | $353 | $24 |
2022: 18 services
| Injection of drug into eye | 223 | $90,717 | $87 |
| Return visit (30+ min) | 355 | $54,491 | $79 |
| Established patient complete exam of visual system | 596 | $52,018 | $64 |
| Imaging of retina | 913 | $36,072 | $22 |
| Removal of eye fluid (vitreous) between lens and retina | 18 | $11,755 | $653 |
| Removal of cataract with insertion of prosthetic lens | 23 | $11,490 | $442 |
| New patient complete exam of visual system | 73 | $5,024 | $69 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $4,783 | $266 |
| New patient visit (45+ min) | 51 | $4,736 | $93 |
| Injection of drug into eye | 15 | $1,595 | $64 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 36 | $1,561 | $37 |
| Measurement of corneal curvature and depth of eye | 34 | $849 | $25 |
| Established patient complete exam of visual system | 13 | $580 | $41 |
| Imaging of retina | 30 | $529 | $15 |
| Photography of the retina | 20 | $443 | $18 |
| Exam of visual field with extended testing | 18 | $430 | $23 |
| Imaging of optic nerve | 15 | $286 | $19 |
| Ct scan of cornea | 11 | $181 | $15 |
2021: 18 services
| Injection of drug into eye | 220 | $100,766 | $94 |
| Established patient complete exam of visual system | 608 | $57,856 | $67 |
| Return visit (30+ min) | 262 | $48,736 | $84 |
| Imaging of retina | 882 | $37,050 | $23 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 11 | $12,340 | $1,122 |
| Removal of cataract with insertion of prosthetic lens | 19 | $10,778 | $469 |
| New patient complete exam of visual system | 128 | $10,446 | $82 |
| Established patient complete exam of visual system | 41 | $3,532 | $58 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,331 | $303 |
| Injection of drug into eye | 15 | $2,984 | $90 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 58 | $2,516 | $39 |
| New patient visit (45+ min) | 20 | $2,282 | $114 |
| Imaging of retina | 43 | $1,232 | $20 |
| Measurement of corneal curvature and depth of eye | 33 | $938 | $28 |
| Exam of visual field with extended testing | 24 | $574 | $24 |
| Established patient problem focused exam of visual system | 11 | $541 | $45 |
| Photography of the retina | 17 | $365 | $19 |
| Ct scan of cornea | 12 | $225 | $19 |
2020: 17 services
| Injection of drug into eye | 205 | $106,596 | $98 |
| Return visit (30+ min) | 469 | $52,950 | $66 |
| Imaging of retina | 665 | $28,833 | $22 |
| Established patient complete exam of visual system | 289 | $23,091 | $68 |
| Removal of cataract with insertion of prosthetic lens | 18 | $12,491 | $520 |
| Long return visit (40+ min) | 73 | $6,982 | $96 |
| New patient visit (45+ min) | 62 | $5,873 | $95 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $4,444 | $317 |
| Established patient complete exam of visual system | 43 | $3,829 | $61 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 53 | $2,256 | $39 |
| Injection of drug into eye | 13 | $2,230 | $77 |
| Established patient problem focused exam of visual system | 26 | $1,358 | $50 |
| Imaging of retina | 44 | $1,348 | $20 |
| Short return visit (20+ min) | 26 | $1,294 | $42 |
| Measurement of corneal curvature and depth of eye | 25 | $726 | $29 |
| Photography of the retina | 19 | $354 | $19 |
| Ct scan of cornea | 11 | $231 | $18 |
2019: 20 services
| Injection of drug into eye | 230 | $116,430 | $99 |
| Return visit (30+ min) | 643 | $76,881 | $66 |
| Imaging of retina | 853 | $36,288 | $22 |
| Removal of cataract with insertion of prosthetic lens | 22 | $16,341 | $584 |
| Long return visit (40+ min) | 122 | $11,809 | $96 |
| Established patient complete exam of visual system | 156 | $11,751 | $69 |
| New patient visit (45+ min) | 112 | $11,269 | $101 |
| Removal of eye fluid (vitreous) between lens and retina | 14 | $10,665 | $667 |
| Injection of drug into eye | 20 | $5,161 | $99 |
| Established patient complete exam of visual system | 55 | $4,495 | $62 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $4,290 | $306 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 64 | $2,628 | $38 |
| Imaging of retina | 58 | $1,963 | $22 |
| New patient visit (60+ min) | 13 | $1,835 | $141 |
| Established patient problem focused exam of visual system | 23 | $1,289 | $48 |
| Measurement of corneal curvature and depth of eye | 32 | $903 | $28 |
| New patient visit (30+ min) | 15 | $823 | $55 |
| Short return visit (20+ min) | 15 | $817 | $45 |
| 2d ultrasound scan of eye tissue and structures | 11 | $575 | $34 |
| Photography of the retina | 20 | $455 | $20 |
2018: 17 services
| Injection of drug into eye | 236 | $113,622 | $98 |
| Return visit (30+ min) | 637 | $74,533 | $64 |
| Imaging of retina | 780 | $33,805 | $22 |
| Long return visit (40+ min) | 106 | $10,417 | $95 |
| Removal of cataract with insertion of prosthetic lens | 14 | $10,150 | $564 |
| New patient visit (45+ min) | 97 | $9,815 | $101 |
| Established patient complete exam of visual system | 120 | $9,282 | $70 |
| Removal of recurring cataract in lens capsule using a laser | 22 | $8,019 | $308 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 65 | $2,697 | $38 |
| New patient visit (60+ min) | 13 | $1,838 | $141 |
| Short return visit (20+ min) | 28 | $1,550 | $44 |
| Established patient problem focused exam of visual system | 19 | $984 | $49 |
| New patient visit (30+ min) | 18 | $843 | $47 |
| Measurement of corneal curvature and depth of eye | 22 | $652 | $30 |
| 2d ultrasound scan of eye tissue and structures | 11 | $505 | $39 |
| Imaging of retina | 15 | $368 | $25 |
| Photography of the retina | 20 | $326 | $16 |
2017: 15 services
| Injection of drug into eye | 215 | $108,290 | $96 |
| Return visit (30+ min) | 629 | $73,589 | $65 |
| Imaging of retina | 688 | $29,123 | $22 |
| Removal of eye fluid (vitreous) between lens and retina | 16 | $13,800 | $690 |
| New patient visit (45+ min) | 115 | $11,868 | $103 |
| Removal of cataract with insertion of prosthetic lens | 13 | $7,610 | $544 |
| Established patient complete exam of visual system | 72 | $5,559 | $69 |
| Long return visit (40+ min) | 51 | $5,069 | $97 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 48 | $2,125 | $39 |
| Short return visit (20+ min) | 24 | $1,390 | $42 |
| Established patient problem focused exam of visual system | 16 | $884 | $49 |
| New patient visit (30+ min) | 13 | $632 | $49 |
| 2d ultrasound scan of eye tissue and structures | 11 | $498 | $36 |
| Measurement of corneal curvature and depth of eye | 17 | $473 | $28 |
| Photography of the retina | 21 | $346 | $16 |
2016: 13 services
| Injection of drug into eye | 201 | $98,391 | $95 |
| Established patient complete exam of visual system | 440 | $46,982 | $66 |
| Imaging of retina | 593 | $30,100 | $25 |
| Return visit (30+ min) | 293 | $25,797 | $68 |
| Removal of eye fluid (vitreous) between lens and retina | 18 | $15,923 | $758 |
| Removal of cataract with insertion of prosthetic lens | 14 | $9,710 | $571 |
| New patient visit (45+ min) | 84 | $8,677 | $103 |
| Long return visit (40+ min) | 76 | $7,454 | $97 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 49 | $3,869 | $43 |
| New patient complete exam of visual system | 26 | $1,826 | $70 |
| Short return visit (20+ min) | 14 | $729 | $46 |
| Photography of the retina | 19 | $579 | $22 |
| Measurement of corneal curvature and depth of eye | 18 | $524 | $29 |
2015: 17 services
| Injection, aflibercept, 1 mg | 49 | $432,993 | None |
| Injection of drug into eye | 154 | $66,931 | $87 |
| Established patient complete exam of visual system | 376 | $46,808 | $70 |
| Injection of drug into eye | 82 | $38,361 | $107 |
| Established patient complete exam of visual system | 150 | $29,862 | $120 |
| Imaging of retina | 396 | $19,560 | $26 |
| Imaging of retina | 172 | $14,387 | $45 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 11 | $12,077 | $1,098 |
| Return visit (30+ min) | 62 | $6,246 | $86 |
| Return visit (30+ min) | 70 | $4,797 | $63 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 55 | $4,529 | $41 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 24 | $4,307 | $110 |
| Unclassified biologics | 28 | $3,824 | None |
| New patient visit (45+ min) | 23 | $2,276 | $99 |
| New patient complete exam of visual system | 27 | $2,262 | $84 |
| Long return visit (40+ min) | 17 | $1,591 | $94 |
| Photography of the retina | 15 | $379 | $22 |
2014: 20 services
| Injection, aflibercept, 1 mg | 43 | $418,301 | None |
| Injection of drug into eye | 165 | $70,232 | $87 |
| Established patient complete exam of visual system | 356 | $40,673 | $70 |
| Injection of drug into eye | 78 | $38,293 | $101 |
| Imaging of retina | 426 | $22,037 | $26 |
| Removal of eye fluid (vitreous) between lens and retina | 23 | $21,628 | $901 |
| Established patient complete exam of visual system | 118 | $21,285 | $114 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $17,869 | $1,375 |
| Return visit (30+ min) | 186 | $14,299 | $62 |
| Imaging of retina | 156 | $13,784 | $43 |
| Return visit (30+ min) | 99 | $12,165 | $88 |
| Unclassified biologics | 39 | $5,436 | None |
| Exam of retinal blood vessels using a special camera after injection of a dye | 60 | $4,878 | $42 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 33 | $4,407 | $107 |
| Long return visit (40+ min) | 25 | $2,565 | $95 |
| Long return visit (40+ min) | 18 | $2,259 | $126 |
| New patient complete exam of visual system | 29 | $2,241 | $77 |
| New patient visit (45+ min) | 23 | $2,036 | $89 |
| Short return visit (20+ min) | 34 | $1,550 | $41 |
| Photography of the retina | 23 | $599 | $22 |
2013: 20 services
| Injection, aflibercept, 1 mg | 30 | $250,378 | None |
| Injection of drug into eye | 160 | $64,273 | $87 |
| Return visit (30+ min) | 346 | $31,510 | $65 |
| Injection of drug into eye | 58 | $24,755 | $99 |
| Established patient complete exam of visual system | 203 | $20,885 | $70 |
| Imaging of retina | 394 | $18,550 | $25 |
| Return visit (30+ min) | 101 | $16,168 | $95 |
| Established patient complete exam of visual system | 68 | $11,192 | $114 |
| Imaging of retina | 117 | $10,530 | $43 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 85 | $6,563 | $41 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 24 | $5,285 | $102 |
| New patient visit (45+ min) | 42 | $4,414 | $105 |
| Unclassified biologics | 32 | $4,123 | None |
| Short return visit (20+ min) | 46 | $2,173 | $43 |
| New patient complete exam of visual system | 18 | $1,615 | $90 |
| Long return visit (40+ min) | 12 | $1,538 | $128 |
| Long return visit (40+ min) | 13 | $1,269 | $91 |
| Short return visit (20+ min) | 14 | $819 | $58 |
| 2d ultrasound scan of eye tissue and structures | 14 | $790 | $46 |
| Photography of the retina | 14 | $377 | $21 |
Medicaid work
$99,714 in 2024
Medicaid paid $99,714 for 1,643 billed services this clinician did in 2024, up to 73 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravitreal injection of a pharmacologic agent (separate procedure) | 567 | $78,313 |
| Return visit (30+ min) | 185 | $7,985 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 580 | $7,806 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 298 | $5,571 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 13 | $39 |
| 2024 | 1,643 | 5 | 73 | $99,714 |
| 2023 | 1,679 | 5 | 66 | $156,063 |
| 2022 | 1,275 | 4 | 46 | $60,242 |
| 2021 | 1,407 | 4 | 53 | $88,812 |
| 2020 | 1,064 | 4 | 45 | $55,208 |
| 2019 | 1,527 | 4 | 51 | $71,606 |
| 2018 | 1,445 | 4 | 46 | $79,529 |
See the largest Medicaid services in earlier years
2023
| Intravitreal injection of a pharmacologic agent (separate procedure) | 565 | $71,220 |
| Aflibercept injection | 54 | $66,754 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 567 | $7,303 |
| Return visit (30+ min) | 231 | $5,517 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 262 | $5,269 |
2022
| Intravitreal injection of a pharmacologic agent (separate procedure) | 362 | $45,163 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 518 | $6,313 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 215 | $4,589 |
| Return visit (30+ min) | 180 | $4,177 |
2021
| Intravitreal injection of a pharmacologic agent (separate procedure) | 351 | $74,259 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 668 | $7,162 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 256 | $4,050 |
| Return visit (30+ min) | 132 | $3,341 |
2020
| Intravitreal injection of a pharmacologic agent (separate procedure) | 412 | $46,814 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 434 | $4,493 |
| Return visit (30+ min) | 181 | $3,576 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 37 | $324 |
2019
| Intravitreal injection of a pharmacologic agent (separate procedure) | 475 | $57,788 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 674 | $6,920 |
| Return visit (30+ min) | 315 | $6,564 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 63 | $333 |
2018
| Intravitreal injection of a pharmacologic agent (separate procedure) | 467 | $64,775 |
| Return visit (30+ min) | 325 | $8,004 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 558 | $6,529 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 95 | $221 |
Drugs they prescribed that Part D paid
$19,505
Pharmacies billed $19,505 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
138 generic and 138 brand-name prescriptions · $19,505 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 91 | $4,042 | $44 |
| Brimonidine | 12 | $1,862 | $155 |
| Ketorolac Tromethamine | 44 | $997 | $23 |
| Dorzolamide-Timolol | 26 | $372 | $14 |
| Timolol Maleate | 22 | $118 | $5 |
See all 6 drugs
| Prednisolone Acetate | 91 | $4,042 | $44 |
| Brimonidine | 12 | $1,862 | $155 |
| Ketorolac Tromethamine | 44 | $997 | $23 |
| Dorzolamide-Timolol | 26 | $372 | $14 |
| Timolol Maleate | 22 | $118 | $5 |
| Latanoprost | 19 | $81 | $4 |
Year by year
| 2024 | 276 | 96 | None | 50% | $19,505 |
| 2023 | 224 | 89 | 0% (0) | 42% | $14,696 |
| 2022 | 276 | 94 | None | 50% | $19,150 |
| 2021 | 291 | 90 | None | 57% | $32,411 |
| 2020 | 268 | 82 | None | 56% | $30,083 |
| 2019 | 249 | 98 | 0% (0) | 55% | $25,195 |
| 2018 | 305 | 106 | None | 44% | $22,469 |
| 2017 | 254 | 83 | None | 41% | $16,704 |
| 2016 | 158 | 61 | None | 45% | $12,852 |
| 2015 | 146 | 53 | None | 51% | $10,466 |
| 2014 | 152 | 51 | None | 63% | $12,486 |
| 2013 | 132 | 48 | None | 62% | $7,453 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Prednisolone Acetate | 65 | $3,251 | $50 |
| Brimonidine | 14 | $1,757 | $126 |
| Ketorolac Tromethamine | 30 | $900 | $30 |
| Timolol Maleate | 23 | $363 | $16 |
| Latanoprost | 16 | $334 | $21 |
| Erythromycin | 14 | $155 | $11 |
| Acyclovir | 11 | $114 | $10 |
2022: 6 drugs
| Prednisolone Acetate | 78 | $4,737 | $61 |
| Durezol | 12 | $2,676 | $223 |
| Ketorolac Tromethamine | 32 | $1,058 | $33 |
| Dorzolamide-Timolol | 12 | $510 | $42 |
| Latanoprost | 28 | $426 | $15 |
| Timolol Maleate | 25 | $193 | $8 |
2021: 8 drugs
| Durezol | 41 | $8,726 | $213 |
| Xiidra | 12 | $6,908 | $576 |
| Prednisolone Acetate | 45 | $3,071 | $68 |
| Latanoprost | 51 | $1,329 | $26 |
| Dorzolamide-Timolol | 21 | $941 | $45 |
| Brimonidine | 11 | $721 | $66 |
| Ketorolac Tromethamine | 18 | $711 | $39 |
| Timolol Maleate | 25 | $275 | $11 |
2020: 8 drugs
| Durezol | 55 | $11,427 | $208 |
| Brimonidine | 16 | $2,940 | $184 |
| Prednisolone Acetate | 35 | $2,395 | $68 |
| Latanoprost | 54 | $1,012 | $19 |
| Ketorolac Tromethamine | 19 | $604 | $32 |
| Olopatadine | 14 | $453 | $32 |
| Dorzolamide-Timolol | 11 | $434 | $39 |
| Timolol Maleate | 17 | $364 | $21 |
2019: 7 drugs
| Durezol | 31 | $6,544 | $211 |
| Prednisolone Acetate | 48 | $2,652 | $55 |
| Brimonidine | 12 | $2,381 | $198 |
| Dorzolamide-Timolol | 17 | $743 | $44 |
| Latanoprost | 42 | $719 | $17 |
| Timolol Maleate | 20 | $628 | $31 |
| Ketorolac Tromethamine | 20 | $549 | $27 |
2018: 7 drugs
| Durezol | 30 | $5,495 | $183 |
| Prednisolone Acetate | 59 | $3,532 | $60 |
| Ketorolac Tromethamine | 47 | $1,129 | $24 |
| Latanoprost | 60 | $868 | $14 |
| Timolol Maleate | 23 | $615 | $27 |
| Dorzolamide-Timolol | 12 | $303 | $25 |
| Erythromycin | 13 | $170 | $13 |
2017: 5 drugs
| Durezol | 39 | $6,379 | $164 |
| Prednisolone Acetate | 43 | $2,553 | $59 |
| Ketorolac Tromethamine | 30 | $854 | $28 |
| Latanoprost | 44 | $661 | $15 |
| Timolol Maleate | 22 | $522 | $24 |
2016: 4 drugs
| Durezol | 16 | $3,095 | $193 |
| Prednisolone Acetate | 26 | $1,829 | $70 |
| Ketorolac Tromethamine | 11 | $407 | $37 |
| Latanoprost | 22 | $314 | $14 |
2015: 4 drugs
| Durezol | 15 | $2,603 | $174 |
| Prednisolone Acetate | 24 | $1,863 | $78 |
| Ketorolac Tromethamine | 14 | $458 | $33 |
| Latanoprost | 24 | $335 | $14 |
2014: 2 drugs
| Durezol | 15 | $2,114 | $141 |
| Prednisolone Acetate | 32 | $2,085 | $65 |
2013: 4 drugs
| Durezol | 19 | $2,126 | $112 |
| Prednisolone Acetate | 29 | $649 | $22 |
| Ketorolac Tromethamine | 13 | $465 | $36 |
| Latanoprost | 13 | $200 | $15 |
Money from drug and device companies
$7,775 in 2025
| 2025 | 2 | 6 | $6,750 | $7,775 |
| 2024 | 3 | 3 | None | $141 |
| 2023 | 2 | 2 | None | $159 |
| 2022 | 4 | 5 | None | $341 |
| 2019 | 1 | 1 | None | $102 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Susvimo | $7,732 | 5 payments
|
| Alcon Vision | Constellation | $43 | 1 payment
|
See all 6 published payments
| Genentech USA | Travel · 2025-07-29 | Susvimo | $313 |
| Genentech USA | Travel · 2025-07-29 | Susvimo | $261 |
| Genentech USA | Consulting · 2025-07-29 | Susvimo | $6,750 |
| Genentech USA | Travel · 2025-07-29 | Susvimo | $215 |
| Genentech USA | Meals · 2025-07-29 | Susvimo | $194 |
| Alcon Vision | Meals · 2025-01-22 | Constellation | $43 |
See earlier years (2024, 2023, 2022, 2019)
2024: $141
| Regeneron Pharmaceuticals | Eylea | $86 | 1 payment
|
| Ocular Therapeutix | Dextenza | $34 | 1 payment
|
| Alcon Vision | Constellation | $21 | 1 payment
|
2023: $159
| Apellis Pharmaceuticals | None | $131 | 1 payment
|
| Genentech USA | Vabysmo | $28 | 1 payment
|
2022: $341
| Genentech | Vabysmo | $214 | 2 payments
|
| Biogen | None | $72 | 1 payment
|
| EyePoint Pharmaceuticals US | Yutiq | $35 | 1 payment
|
| Alcon Vision | Constellation | $21 | 1 payment
|
2019: $102
| Genentech | Lucentis | $102 | 1 payment
|
Professional record
- NPI
- 1356409882
- Licence
- CA G74925California G74925: Current · expires 2028-04-30
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G749250
- Taxonomy
- Federal specialty code 207WX0107X (207WX0107X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 2452 Watson Court, Palo Alto, CA, 94303
- NPI first listed
- 2006-12-05
- NPI last updated
- 2024-04-04
- NPI record certified
- 2024-04-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2452 Watson Court, Palo Alto, CA, 94303